entertainment -WSS

entertainment

author：focus 2025-09-30 18:48:05 - browse：4599

Walmart seems poised to increase its health care footprint by buying value-based senior care company ChenMed. Joe Raedle/Getty Images

Walmart seems poised to increase its health care footprint by buying value-based senior care company ChenMed, per reports from Bloomberg.

Experts largely hailed the rumored sale as a good buy, citing the management of chronic conditions in the Medicare Advantage population through primary care, ChenMed’s specialty, as an area with huge innovation and cost savings over the last 10 years.

“If you’re going to purchase primary care in the senior space, there’s no one better than ChenMed. The only other one that might be better or equivalent would be Oak Street, but they were just purchased,” said Jon Kaplan, a senior partner at BCG. “In the world of great primary care practices to buy, in my top two are Oak Street and ChenMed, and one of them’s available, one’s not.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： ARCH Venture Partners is raising $3 billion for a life sciences fund

WSS

New Ultima Genomics DNA sequencer can read genome for $100

Some dementia cases could be undiagnosed liver disease

Accuser who called Kevin Spacey 'vile sexual predator' admits he joked about incident

Do digital therapeutics have a future in medicine?

Medicare drug price negotiation’s day in court

The U.S. needs a new definition of substance use “recovery”

leisure time

entertainment

explore

ChatGPT in medicine: STAT answers readers' burning questions

Teachers share how revamped forgiveness program helped with their student loans

As demand for Covid shots wanes, Moderna seeks its next success

Home health providers sue Medicare over payment cuts

Duchenne breakthrough therapy leaves behind pioneering families

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

Heart attack and stroke risk calculators need revising

Judge agrees to delay next hearing in Trump classified documents case

The cancer drug shortage isn’t new — and neither are the solutions

Vertigo drug brings hope for rare neuron disorder, Niemann

leisure time

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Congressmen charge Covid hearing ‘could have been an email’

Accuser who called Kevin Spacey 'vile sexual predator' admits he joked about incident

General Catalyst, Summa Health deal will turn on physician buy

Create a giant ice tray with this foil pan hack to keep food cold this summer

Medicare drug price negotiation’s day in court

knowledge

knowledge

focus

entertainment